Research News and Research

RSS

Trilink, TATAA sign deal to sell CleanAmp Products

TriLink BioTechnologies, Inc. announced that it has entered into a distribution agreement with TATAA Biocenter to sell its CleanAmp Products.

28 Mar 2011

Cleveland Clinic, Elsevier to offer physicians with evidence-based clinical content

Elsevier, a world leader in health care and medical publishing and online solutions, today announced a strategic relationship between First Consult and Cleveland Clinic to provide physician-author support of content for First Consult, an evidence-based resource integrated into the clinical workflow to deliver trusted medical information at the point-of-care.

28 Mar 2011

AVEO to present tivozanib preclinical data, monoclonal antibody pipeline at AACR meeting

AVEO Pharmaceuticals, Inc. today announced that preclinical data on tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, and the company's monoclonal antibody pipeline will be presented during poster sessions at the American Association for Cancer Research 102nd Annual Meeting 2011 being held April 2-6, 2011 in Orlando, Fla.

28 Mar 2011

Leicester professor receives Outstanding Alumni Achievement Award for Cardiovascular research

The winner of the University of Leicester inaugural Outstanding Alumni Achievement Award was revealed at the 2011 Alumni Black Tie Dinner on Thursday 17 February at the Mandarin Hotel in London.

28 Mar 2011

Drugs can prevent risk of breast cancer in women, experts say

Drugs could be used to prevent breast cancer in women at high risk of the disease in the same way that statins are used for heart disease if trials looking at ways of predicting risk are successful, according to an international panel of cancer experts.

28 Mar 2011

NMSS grants Adeona's ongoing Trimesta trial with $409,426 to treat MS

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that the ongoing clinical trial of its Trimesta drug candidate has received an additional $409,426 in grant funding from the National Multiple Sclerosis Society.

28 Mar 2011

DAW prescriptions can increase annual health system costs to $7.7 billion

Approximately five percent of prescriptions submitted by CVS Caremark Pharmacy Benefit Management members in a 30-day period during 2009 included a "dispense as written" designation.

28 Mar 2011

MRF: FDA's decision on Yervoy offers new treatment options for patients with melanoma

Thirteen years of waiting is now over for melanoma patients. That's how long it's been since the last therapy became available to treat the most lethal form of skin cancer – melanoma. The FDA today announced approval of Yervoy, an immunotherapy treatment for advanced melanoma.

28 Mar 2011

Research: Written action plan with prescriptions can improve asthma control in children

It sounds unbelievably simple but it's true - a written action plan for asthma treatment, attached to the drug prescription, improves asthma control in children. "Acute care visits for asthma often signal a management failure," said Dr. Francine Ducharme, of the University of Montreal's Department of Pediatrics and the Sainte-Justine University Hospital Centre.

28 Mar 2011

Essex scientists receive £205,000 grant for breast cancer research

Scientists from the University of Essex have received a £205,000 grant from Cancer Research UK to investigate the early reversible changes in the genes associated with breast cancer development.

28 Mar 2011

CBAI partners with BlueCross and offers cord blood banking services to their members

Cord Blood America, Inc., announced today it has entered into an agreement with BlueCross BlueShield of Tennessee and is now offering the storage of umbilical cord blood at a discount rate as consistent with its other BCBS licensee contracts.

28 Mar 2011

Conference to address new treatments, technologies from biomedical research

New treatments and technologies emerging from the field of biomedical research have prompted demands for updated ethical guidelines.

28 Mar 2011

U.S. FDA approves Yervoy to treat patients with late-stage melanoma

The U.S. Food and Drug Administration today approved Yervoy to treat patients with late-stage melanoma, the most dangerous type of skin cancer.

28 Mar 2011

ALCMI launches new CASTLE study to treat lung cancer

The Addario Lung Cancer Medical Institute today announced the enrollment of the initial subjects into its inaugural clinical trial known as CASTLE, targeting 250 subjects over two years among academic and community medical centers in the United States.

28 Mar 2011

University of Aberdeen, TPP enter agreement to develop novel future medicines

TPP Global Development Ltd has announced an agreement with the University of Aberdeen to collaborate on the development of novel pre-clinical intellectual property originated within the University.

28 Mar 2011

Molecular pharmacologist receives AACR Award for cancer research

Susan Band Horwitz, Ph.D., will receive the Eighth Annual AACR Award for Lifetime Achievement in Cancer Research. Horwitz conducted pioneering research by discovering the mechanism of action of the chemotherapeutic drug paclitaxel, which prompted the development of this drug as an important therapy for many common solid tumors, including ovarian, breast, and lung carcinomas.

28 Mar 2011

Study establishes strong link between nicotine and diabetes complications

Scientists today reported the first strong evidence implicating nicotine as the main culprit responsible for persistently elevated blood sugar levels - and the resulting increased risk of serious health complications - in people who have diabetes and smoke.

28 Mar 2011

New discovery provides insight into complex Rad50 molecular motor function

Over the last years, two teams of researchers at The Scripps Research Institute have steadily built a model of how a powerful DNA repair complex works. Now, their latest discovery provides revolutionary insights into the way the molecular motor inside the complex functions - findings they say may have implications for treatment of disorders ranging from cancer to cystic fibrosis.

28 Mar 2011

FDA approves ipilimumab for metastatic melanoma treatment

The U.S. Food and Drug Administration announced today its approval of a new treatment for advanced melanoma, the deadliest and most difficult-to-treat form of skin cancer.

28 Mar 2011

Financial Times examines rise in public, private sector global partnerships for aid delivery

"New models of financing and delivering development programmes are bringing far-reaching changes to the international public sector," with " traditional government-to-government transactions … giving way to complex networks of partners - some of them from the private sector - to provide everything from antiretroviral drugs and girls' education to emergency food supplies," the Financial Times reports in a piece that explores why such changes are taking place and their implications for future funding.

28 Mar 2011